Human biofluid concentrations of mono(2-ethylhexyl)phthalate extrapolated from pharmacokinetics in chimeric mice with humanized liver administered with di(2-ethylhexyl)phthalate and physiologically based pharmacokinetic modeling-Reference-Cited by-同舟云学术

Human biofluid concentrations of mono(2-ethylhexyl)phthalate extrapolated from pharmacokinetics in chimeric mice with humanized liver administered with di(2-ethylhexyl)phthalate and physiologically based pharmacokinetic modeling

Published:2015-05 Issue:3 Volume:39 Page:1067-1073
ISSN:1382-6689
Container-title:Environmental Toxicology and Pharmacology
language:en
Short-container-title:Environmental Toxicology and Pharmacology

Author:

Adachi Koichiro,Suemizu Hiroshi,Murayama Norie,Shimizu Makiko,Yamazaki Hiroshi^ORCID

Funder

Japan Chemical Industry Association's (JCIA) LRI program

Publisher

Elsevier BV

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,General Medicine

Reference33 articles.

1. Pharmacokinetics, interactions with macromolecules and species differences in metabolism of DEHP;Albro;Environ. Health Perspect.,1982

2. Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds;Amidon;Pharm. Res.,1988

3. A twenty-volunteer study using deuterium labelling to determine the kinetics and fractional excretion of primary and secondary urinary metabolites of di-2-ethylhexylphthalate and di-iso-nonylphthalate;Anderson;Food Chem. Toxicol.,2011

4. In vitro metabolism of di(2-ethylhexyl) phthalate (DEHP) by various tissues and cytochrome P450s of human and rat;Choi;Toxicol in Vitro,2012

5. Systems biology and mode of action based risk assessment;Edwards;Toxicol. Sci.,2008

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel approach for verification of a human PBPK modeling strategy using chimeric mice in the health risk assessment of epyrifenacil;Toxicology and Applied Pharmacology;2023-04

2. Modeling di (2-ethylhexyl) Phthalate (DEHP) and Its Metabolism in a Body’s Organs and Tissues through Different Intake Pathways into Human Body;International Journal of Environmental Research and Public Health;2022-05-09

3. Comparison of the exposure assessment of di(2-ethylhexyl) phthalate between the PBPK model-based reverse dosimetry and scenario-based analysis: A Korean general population study;Chemosphere;2022-05

4. Prediction of the human pharmacokinetics of epyrifenacil and its major metabolite, S-3100-CA, by a physiologically based pharmacokinetic modeling using chimeric mice with humanized liver;Toxicology and Applied Pharmacology;2022-03

5. Toxicokinetics of mono-(2-ethylhexyl) phthalate with low-dose exposure applying fluorescence tracing technique;Toxicology and Applied Pharmacology;2022-01